Table 1.
Dose (mg/kg BW) | Route | Sex | Endpoint | Use in Model Development | |
---|---|---|---|---|---|
Kemper, Experiment 1 | 1.0 | Oral | M and F | cumulative dose in urine and feces | calibration |
Kemper, Experiment 2 | 5.0 | Oral | M and F | cumulative dose in urine and feces | evaluation |
Kemper, Experiment 3 | 25.0 | Oral | M and F | cumulative dose in urine and feces | evaluation |
Kemper, Experiment 5 | 0.1 | Oral | M and F | serum concentration | evaluation |
Kemper, Experiment 6a | 1.0 | Oral | M and F | serum concentration | calibration |
Kemper, Experiment 6b | 1.0 | IV | M and F | serum concentration | calibration (M), evaluation (F) |
Kemper, Experiment 7 | 5.0 | Oral | M and F | serum concentration | evaluation |
Kemper, Experiment 8 | 25.0 | Oral | M and F | serum concentration | evaluation |
Kudo, Experiment 1 | 0.041 | IV | M | serum and liver concentration | evaluation |
Kudo, Experiment 2 | 16.56 | IV | M | serum and liver concentration | evaluation |
References: Kemper, R.A, 2003 and Kudo, N., et al., 2002.